Announcements

Reliance acquire Lithium Werks for $61 million

Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

TCS net profit up 12.3% at ₹9,769 crore; revenue up 16.3%

Infosys beats market estimates; profit up 12%, raises guidance

Latest

Mar 14, 2022

Reliance acquire Lithium Werks for $61 million

Apr 08, 2011

Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

Jan 12, 2022

TCS net profit up 12.3% at ₹9,769 crore; revenue up 16.3%

Jan 12, 2022

Infosys beats market estimates; profit up 12%, raises guidance

Jan 11, 2022

IPO: Sresta Natural Bioproducts files draft papers with SEBI

Jan 09, 2022

Avenue Supermarts Q3 results: Standalone net profit rises 25% to ₹586 crore

Apr 14, 2021

Infosys Q4 results present a mixed bag

May 04, 2021

Mutuality principle: Bowring Institute gets AAR reprieve on GST

Apr 26, 2021

Ahammune Biosciences raises Pre-Series A funding from Ideaspring Capital, Indian Angel Network

May 05, 2021

Apollo Computing Labs unveils SwasthVayu, a non-invasive ventilator

Apr 14, 2021

Infosys Q4 results present a mixed bag

Mar 14, 2022

Reliance acquire Lithium Werks for $61 million

Apr 08, 2011

Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

Jan 12, 2022

TCS net profit up 12.3% at ₹9,769 crore; revenue up 16.3%

Jan 12, 2022

Infosys beats market estimates; profit up 12%, raises guidance

Jan 11, 2022

IPO: Sresta Natural Bioproducts files draft papers with SEBI

Jan 09, 2022

Avenue Supermarts Q3 results: Standalone net profit rises 25% to ₹586 crore

Apr 14, 2021

Infosys Q4 results present a mixed bag

May 04, 2021

Mutuality principle: Bowring Institute gets AAR reprieve on GST

Apr 26, 2021

Ahammune Biosciences raises Pre-Series A funding from Ideaspring Capital, Indian Angel Network

May 05, 2021

Apollo Computing Labs unveils SwasthVayu, a non-invasive ventilator

Apr 14, 2021

Infosys Q4 results present a mixed bag

Other

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

From ripping the road to carving corners on the track!

Signing up to ride RE’s Continental GT Cup race-spec can help you hone skills for the road and the track. Built around the stock bike, it can also g

Chips Ahoy!

The EV race looks set to be a high voltage thriller with brands that have no history of car-making entering the fray. Will access to cells and chips b

Chip shortage: Buyers go for new Creta variants with lesser features

Buyers opt for the Creta models with lower number of semiconductors to avoid the long waiting period

How to play the current market correction

Though the earnings outlook is uncertain at this point, investors can still capitalise on the fall in two ways

Pharma opportunities and threats after market correction

Pharma stocks corrected in line with the bellwether index (average 10 per cent) since October 19, 2021, with some stocks (Lupin, Zydus Lifesciences an

Financials attractive after market decline, but warrant caution

While the broader indices peaked on October 19, 2021., bank stocks joined the rally about a week later - on October 25. But since its peak, foreign in

Auroville: An utopian search for a better world

Akash Kapur’s ‘Better to Have Gone’ traces what happens when we believe deeply in a quest and give up everything in its pursuit

Lady doctors and the rocky path to healing

A handbook on India’s first women doctors holds up a mirror to the social and political realities of the 19th and early 20th century

Conquering Everest: A compelling account of how an impossible dream was achieved

Jim Davidson dwells in detail on the failure to make it in the first attempt and the harrowing return to physically and emotionally draining climb up